Logo (Actavis) 347 Pill - red capsule/oblong, 14mm
Pill with imprint Logo (Actavis) 347 is Red, Capsule/Oblong and has been identified as Morphine Sulfate Extended-Release 200 mg. It is supplied by Actavis Pharma, Inc.
Morphine is used in the treatment of Chronic Pain; Neonatal Abstinence Syndrome; Pain and belongs to the drug class Opioids (narcotic analgesics). Risk cannot be ruled out during pregnancy. Morphine 200 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for Logo (Actavis) 347
Morphine Sulfate Extended-Release
- Imprint
- Logo (Actavis) 347
- Strength
- 200 mg
- Color
- Red
- Size
- 14.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Opioids (narcotic analgesics)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Actavis Pharma, Inc.
- National Drug Code (NDC)
- 00228-4347
- Inactive Ingredients
-
lactose anhydrous,
magnesium stearate,
magnesium silicate,
titanium dioxide,
ferric oxide red,
ferric oxide yellow,
polyethylene glycol,
cetostearyl alcohol
Note: Inactive ingredients may vary.
More about morphine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (372)
- Drug images
- Latest FDA alerts (12)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: Opioids (narcotic analgesics)
- Breastfeeding
Patient resources
- Morphine drug information
- Morphine injection
- Morphine (Epidural) (Advanced Reading)
- Morphine (Injection) (Advanced Reading)
- Morphine (Oral) (Advanced Reading)
Other brands
MS Contin, Roxanol, Kadian, Avinza, ... +10 more
Professional resources
- Morphine monograph
- Morphine ER (FDA)
- Morphine Extended Release Capsules (FDA)
- Morphine Injection (FDA)
- Morphine Oral Solution (FDA)
Other brands
MS Contin, Kadian, Astramorph PF, Duramorph, ... +4 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
